Biogen (BIIB)
(Real Time Quote from BATS)
$190.64 USD
-3.48 (-1.79%)
Updated Sep 25, 2024 12:30 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Brokerage Reports
Biogen Inc. [BIIB]
Reports for Purchase
Showing records 1 - 20 ( 835 total )
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BIIB 092324
Provider: Stock Traders Daily
Analyst: Research Department
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BIIB 091624
Provider: Stock Traders Daily
Analyst: Research Department
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Are We There Yet? Turnaround Story Continues To Evolve
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Alzheimer''s Treatment Landscape Getting Ready for Combination Therapies
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
2Q24 First Take: Strong Showing With Top/Bottom-Line Beat, Hi-Bio In Spotlight
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
ET KOL Check: Delving Into The Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
INVITE: ET KOL Call - Delving Into The Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L